Early elevation of interleukin-1β and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina

Thrombosis Research

Volumn 117, Issue 6, 2006, Pages 659-664

  Sardella, Gennaro ^a   Mariani, Paola ^a   D'Alessandro, Mariadomenica ^a   De Luca, Leonardo ^a   Pierro, Marianna ^a   Mancone, Massimo ^a   Porretta, Alessandro ^a   Accapezzato, Daniele ^a   Fedele, Francesco ^a   Paroli, Marino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Drug eluting stents; Inflammation; Interleukin 1 ; Interleukin 6

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; METAL; PACLITAXEL; RAPAMYCIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; CYTOKINE RELEASE; DRUG ELUTING STENT; FEMALE; HUMAN; IMMUNE RESPONSE; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STABLE ANGINA PECTORIS; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS;

EID: 33646064999     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.06.002     Document Type: Article

References (25)

1. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331 (1994) 496-501
2. Rajagopal V., and Rockson S.G. Coronary restenosis: a review of mechanisms and management. Am J Med 115 (2003) 547-553
3. Schwartz R.S., and Henry T.D. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 3 (2002) S4-S9
4. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
5. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
6. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16 (1998) 457-499
7. Loppnow H., Bil R., Hirt S., Schonbeck U., Herzberg M., Werdan K., et al. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91 (1998) 134-141
8. Chamberlain J., Gunn J., Francis S., Holt C., and Crossman D. Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries. Cardiovasc Res 44 (1999) 156-165
9. Shimokawa H., Ito A., Fukumoto Y., Kadokami T., Nakaike R., Sakata M., et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 97 (1996) 769-776
10. Oemar B.S. Is interleukin-1 beta a triggering factor for restenosis?. Cardiovasc Res 44 (1999) 17-19
11. Isoda K., Shiigai M., Ishigami N., Matsuki T., Horai R., Nishikawa K., et al. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation 108 (2003) 516-518 [Electronic publication 2003 Jul 21]
12. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1-78
13. Ikeda U. Inflammation and coronary artery disease. Curr Vasc Pharmacol 1 (2003) 65-70
14. Kefer J.M., Galanti L.M., and Hanet C.E. Time course of transcardiac interleukin-6 release after coronary stenting for stable angina. Heart 90 (2004) 943-944
15. Aggarwal A., Schneider D.J., Terrien E.F., Gilbert K.E., and Dauerman H.L. Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response. J Thromb Thrombolysis 15 (2003) 25-31
16. Sardella G., Accapezzato D., Di Roma A., Iacoboni C., Francavilla V., Benedetti G., et al. Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int J Immunopathol Pharmacol 17 (2004) 165-170
17. Paroli M., Mariani P., Accapezzato D., D'Alessandro M., Di Russo C., Bifolco M., et al. Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization. Clin Immunol 112 (2004) 78-84
18. Lau K.W., Mak K.H., Hung J.S., and Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention. Am Heart J 147 (2004) 764-773
19. Dehmer G.J., Nichols T.C., Li S., Koch G.G., Tate D.A., and Griggs T.R. Effects of an ionic and nonionic contrast agent on von Willebrand factor assessed during coronary angiography. Am J Cardiol 84 (1999) 223-225 [A8]
20. Bhatia V., Bhatia R., and Dhindsa M. Drug-eluting stents: new era and new concerns. Postgrad Med J 80 (2004) 13-18
21. Ibbotson T., McGavin J.K., and Goa K.L. Abciximab: an updated review of its therapeutic use in patients with ischemic heart disease undergoing percutaneous coronary revascularization. Drugs 63 (2003) 1121-1163
22. Nagasaki K., Matsumoto K., Kaneda M., Shintani T., Shibutani S., Murayama T., et al. Effects of preinjury administration of corticosteroids on pseudointimal hyperplasia and cytokine response in a rat model of balloon aortic injury. World J Surg 28 (2004) 910-916
23. Hoshida S., Nishino M., Takeda T., Tanouchi J., Yamada Y., and Hori M. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 173 (2004) 285-290
24. Braddock M., and Quinn A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3 (2004) 330-339
25. Dinarello C.A. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4 (2004) 378-385